Unsaturated fatty acids prevent desensitization of the human growth hormone secretagogue receptor by blocking its internalization

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 3, 2010, Pages

  Delhanty, Patric J D ^a   Van Kerkwijk, Anke ^a   Huisman, Martin ^a   Van De Zande, Bedette ^a   Verhoef Post, Miriam ^a   Gauna, Carlotta ^a   Hofland, Leo ^a   Themmen, Axel P N ^a   Van Der Lely, A J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ghrelin receptor fatty acids

Indexed keywords

CHOLESTEROL; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; LINOLEIC ACID; LIPID; OLEIC ACID; UNSATURATED FATTY ACID; AEQUORIN; GHRELIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; DESENSITIZATION; ENZYME ACTIVATION; ENZYME MECHANISM; FATTY ACID METABOLISM; GROWTH HORMONE RELEASE; GROWTH INHIBITION; IN VITRO STUDY; INCUBATION TIME; INTERNALIZATION; LIPID RAFT; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR SENSITIVITY; ANIMAL; ANTAGONISTS AND INHIBITORS; BINDING COMPETITION; CHEMISTRY; CHO CELL LINE; CRICETULUS; DOSE RESPONSE; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HAMSTER; LUMINESCENCE; METABOLISM;

AEQUORIN; ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CHOLESTEROL; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GHRELIN; LINOLEIC ACID; LUMINESCENCE; MICROSCOPY, FLUORESCENCE; OLEIC ACID; RECEPTORS, GHRELIN;

EID: 77956807621     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00414.2009     Document Type: Article

References (64)

1. Aguilera CM, Gil-Campos M, Canete R, Gil A. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome. Clin Sci (Lond) 114: 183-193, 2008.
2. Alberts GL, Chio CL, Im WB. Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds. Mol Pharmacol 60: 1349-1355, 2001.
3. Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf) 61: 250-255, 2004. (Pubitemid 39093122)
4. Askari B, Carroll MA, Capparelli M, Kramer F, Gerrity RG, Bornfeldt KE. Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J Biol Chem 277: 36338-36344, 2002.
5. Barb CR, Kraeling RR, Barrett JB, Rampacek GB, Campbell RM, Mowles TF. Serum glucose and free fatty acids modulate growth hormone and luteinizing hormone secretion in the pig. Proc Soc Exp Biol Med 198: 636-642, 1991.
6. Beattie ME, Veatch SL, Stottrup BL, Keller SL. Sterol structure determines miscibility versus melting transitions in lipid vesicles. Biophys J 89: 1760-1768, 2005.
7. Becher A, McIlhinney RA. Consequences of lipid raft association on G-protein-coupled receptor function. Biochem Soc Symp: 151-164, 2005.
8. Berlin E, Hannah JS, Yamane K, Peters RC, Howard BV. Fatty acid modification of membrane fluidity in Chinese hamster ovary (TR715-19) cells. Int J Biochem Cell Biol 28: 1131-1139, 1996. (Pubitemid 26361890)
9. Bewick GA, Kent A, Campbell D, Patterson M, Ghatei MA, Bloom SR, Gardiner JV. Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivity. Diabetes 58: 840-846, 2009.
10. Bounoutas GS, Tawfeek H, Fröhlich LF, Chung UI, Abou-Samra AB. Impact of impaired receptor internalization on calcium homeostasis in knock-in mice expressing a phosphorylation-deficient parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology 147: 4674-4679, 2006.
11. Broglio F, Benso A, Gottero C, Prodam F, Grottoli S, Tassone F, Maccario M, Casanueva FF, Dieguez C, Deghenghi R, Ghigo E, Arvat E. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 57: 265-271, 2002.
12. Bruneau C, Hubert P, Waksman A, Beck JP, Staedel-Flaig C. Modifications of cellular lipids induce insulin resistance in cultured hepatoma cells. Biochim Biophys Acta 928: 297-304, 1987. (Pubitemid 17116161)
13. Bucci C, Seru R, Annella T, Vitelli R, Lattero D, Bifulco M, Mondola P, Santillo M. Free fatty acids modulate LDL receptor activity in BHK-21 cells. Atherosclerosis 137: 329-340, 1998.
14. Camiña JP, Carreira MC, El Messari S, Llorens-Cortes C, Smith RG, Casanueva FF. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 145: 930-940, 2004. (Pubitemid 38183837)
15. Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B, Scanlon MF, Schally AV, Fernandez-Cruz A. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab 65: 634-642, 1987.
16. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 100: 1152-1157, 2008.
17. Court JM, Dunlop ME, Leonard RF. High-frequency oscillation of blood free fatty acid levels in man. J Appl Physiol 31: 345-347, 1971.
18. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114: 57-66, 2004.
19. Eyster KM. The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist. Adv Physiol Educ 31: 5-16, 2007.
20. Fielding CJ, Fielding PE. Membrane cholesterol and the regulation of signal transduction. Biochem Soc Trans 32: 65-69, 2004. (Pubitemid 38283015)
21. Fielding CJ, Fielding PE. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta 1610: 219-228, 2003.
22. Funari SS, Barcelo F, Escriba PV. Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes. J Lipid Res 44: 567-575, 2003.
23. Gauna C, van de Zande B, van Kerkwijk A, Themmen AP, van der Lely AJ, Delhanty PJ. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R). Mol Cell Endocrinol 274: 30-34, 2007.
24. Glaser M, Ferguson KA, Vagelos PR. Manipulation of the phospholipid composition of tissue culture cells. Proc Natl Acad Sci USA 71: 4072-4076, 1974.
25. Holliday ND, Holst B, Rodionova EA, Schwartz TW, Cox HM. Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol 21: 3100-3112, 2007. (Pubitemid 350223518)
26. Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW. High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol Endocrinol 17: 2201-2210, 2003.
27. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974-977, 1996. (Pubitemid 26275178)
28. Ikonen E, Heino S, Lusa S. Caveolins and membrane cholesterol. Biochem Soc Trans 32: 121-123, 2004.
29. Kawczynska-Drozdz A, Olszanecki R, Jawien J, Brzozowski T, Pawlik WW, Korbut R, Guzik TJ. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 19: 764-767, 2006. (Pubitemid 43928520)
30. Kilianova Z, Basora N, Kilian P, Payet MD, Gallo-Payet N. Human melanocortin receptor 2 expression and functionality: effects of protein kinase A and protein kinase C on desensitization and internalization. Endocrinology 147: 2325-2337, 2006.
31. Kishi M, Ascoli M. The C-terminal tail of the rat lutropin/ choriogonadotropin (CG) receptor independently modulates human (h)CG-induced internalization of the cell surface receptor and the lysosomal targeting of the internalized hCG-receptor complex. Mol Endocrinol 14: 926-936, 2000.
32. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 85: 495-522, 2005.
33. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin - a hormone with multiple functions. Front Neuroendocrinol 25: 27-68, 2004.
34. Koutkia P, Meininger G, Canavan B, Breu J, Grinspoon S. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy. Am J Physiol Endocrinol Metab 286: E296-E303, 2004.
35. Loesberg C, Spence S, Nijkamp FP, Houslay MD. Dietary linoleic acid-induced changes in respiratory beta-adrenergic receptor function and the form of arrhenius plots of isoprenaline- and prostaglandin E2-stimulated adenylate cyclase activity in a model for atopy. Cell Signal 6: 187-199, 1994. (Pubitemid 24185998)
36. Lopez M, Vidal-Puig A. Brain lipogenesis and regulation of energy metabolism. Curr Opin Clin Nutr Metab Care 11: 483-490, 2008.
37. Massey JB. Membrane and protein interactions of oxysterols. Curr Opin Lipidol 17: 296-301, 2006.
38. Meuillet EJ, Leray V, Hubert P, Leray C, Cremel G. Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2. Biochim Biophys Acta 1454: 38-48, 1999.
39. Moffett S, Brown DA, Linder ME. Lipid-dependent targeting of G proteins into rafts. J Biol Chem 275: 2191-2198, 2000.
40. Monteleone P, Fabrazzo M, Martiadis V, Fuschino A, Serritella C, Milici N, Maj M. Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder. J Clin Endocrinol Metab 88: 5387-5391, 2003. (Pubitemid 37452743)
41. Monteleone P, Santonastaso P, Pannuto M, Favaro A, Caregaro L, Castaldo E, Zanetti T, Maj M. Enhanced serum cholesterol and triglyceride levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 134: 267-273, 2005.
42. Mukhopadhyay S, Ramminger SJ, McLaughlin M, Gambling L, Olver RE, Kemp PJ. Direct modulation of G-proteins by polyunsaturated fatty acids: a novel eicosanoid-independent regulatory mechanism in the developing lung. Biochem J 326: 725-730, 1997. (Pubitemid 27438045)
43. Nishizaki T, Ikeuchi Y, Matsuoka T, Sumikawa K. Oleic acid enhances ACh receptor currents by activation of Ca2+/calmodulin-dependent protein kinase II. Neuroreport 8: 597-601, 1997. (Pubitemid 27128200)
44. Nishizaki T, Ikeuchi Y, Matsuoka T, Sumikawa K. Short-term depression and long-term enhancement of ACh-gated channel currents induced by linoleic and linolenic acid. Brain Res 751: 253-258, 1997.
45. Parpal S, Karlsson M, Thorn H, Stralfors P. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J Biol Chem 276: 9670-9678, 2001. (Pubitemid 37391862)
46. Pérez FR, Camiña JP, Menéndez C, Beiras A, Casabiell X, Casanueva FF. Cis-unsaturated free fatty acids block VIP-mediated GH and PRL secretion by perturbing the cAMP/protein kinase A pathway. Pituitary 1: 25-32, 1998.
47. Pérez FR, Casabiell X, Camiña JP, Zugaza JL, Casanueva FF. cisunsaturated free fatty acids block growth hormone and prolactin secretion in thyrotropin-releasing hormone-stimulated GH3 cells by perturbing the function of plasma membrane integral proteins. Endocrinology 138: 264-272, 1997.
48. Pike LJ. Lipid rafts: bringing order to chaos. J Lipid Res 44: 655-667, 2003.
49. Richter-Unruh A, Verhoef-Post M, Malak S, Homoki J, Hauffa BP, Themmen AP. Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain. J Clin Endocrinol Metab 89: 5161-5167, 2004.
50. Smith MP, Ayad VJ, Mundell SJ, McArdle CA, Kelly E, López Bernal A. Internalization and desensitization of the oxytocin receptor is inhibited by Dynamin and clathrin mutants in human embryonic kidney 293 cells. Mol Endocrinol 20: 379-388, 2006. (Pubitemid 43152511)
51. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973-7981, 2003. (Pubitemid 37377491)
52. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3: 379-386, 2006.
53. Sun Y, Butte NF, Garcia JM, Smith RG. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149: 843-850, 2008.
54. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101: 4679-4684, 2004. (Pubitemid 38437470)
55. Tawfeek HA, Qian F, Abou-Samra AB. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol Endocrinol 16: 1-13, 2002.
56. Terés S, Barceló-Coblijn G, Benet M, Alvarez R, Bressani R, Halver JE, Escribá PV. Oleic acid content is responsible for the reduction in blood pressure induced by olive oil. Proc Natl Acad Sci USA 105: 13811-13816, 2008.
57. Vacaresse N, Lajoie-Mazenc I, Augé N, Suc I, Frisach MF, Salvayre R, Nègre-Salvayre A. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ Res 85: 892-899, 1999. (Pubitemid 29534163)
58. van der Lely AJ, Tschöp M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25: 426-457, 2004.
59. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77: 53-62, 1994. (Pubitemid 24184687)
60. Witt MR, Westh-Hansen SE, Rasmussen PB, Hastrup S, Nielsen M. Unsaturated free fatty acids increase benzodiazepine receptor agonist binding depending on the subunit composition of the GABAA receptor complex. J Neurochem 67: 2141-2145, 1996.
61. Yaguchi T, Yamamoto S, Nagata T, Kanno T, Tanaka A, Nishizaki T. Effects of cis-unsaturated free fatty acids on PKC-epsilon activation and nicotinic ACh receptor responses. Brain Res Mol Brain Res 133: 320-324, 2005. (Pubitemid 40248423)
62. Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324, 2007.
63. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115: 3564-3572, 2005.
64. Zugaza JL, Casabiell XA, Bokser L, Eiras A, Beiras A, Casanueva FF. Pretreatment with oleic acid accelerates the entrance into the mitotic cycle of EGF-stimulated fibroblasts. Exp Cell Res 219: 54-63, 1995.